Asif Ali
Chief Financial Officer · 4 filings · Latest: Apr 20, 2026
Protagonist Therapeutics, Inc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PTGX | Asif Ali | Chief Financial Officer | Apr 20, 2026 | Sale | $105.47 | 1,750 | $184.6K | 59,003 | |
PTGX | Asif Ali | — | Apr 20, 2026 | Proposed Sale | $105.47 | 1,750 | $184.6K | — | |
PTGX | Asif Ali | Chief Financial Officer | Mar 26, 2026 | Sale | $104.24 | 24,765 | $2.6M | 60,753 | |
PTGX | Asif Ali | Chief Financial Officer | Mar 26, 2026 | Option Exercise | $17.70 | 24,765 | $438.3K | 85,518 | |
PTGX | ASIF ALI | — | Mar 26, 2026 | Proposed Sale | $104.24 | 24,765 | $2.6M | — | |
PTGX | Asif Ali | Chief Financial Officer | Jan 27, 2026 | Sale | $83.13 | 46,203 | $3.8M | 60,320 | |
PTGX | Asif Ali | Chief Financial Officer | Jan 27, 2026 | Option Exercise | $16.18 | 28,000 | $453.1K | 106,523 | |
PTGX | ASIF ALI | — | Jan 27, 2026 | Proposed Sale | $83.14 | 46,203 | $3.8M | — | |
PTGX | Asif Ali | Chief Financial Officer | Jan 20, 2026 | Sale | $82.48 | 8,588 | $708.3K | 78,077 | |
PTGX | Asif Ali | — | Jan 20, 2026 | Proposed Sale | $82.48 | 8,588 | $708.3K | — | |
PTGX | Ali Asif | — | Mar 12, 2025 | Proposed Sale | $58.73 | 24,903 | $1.5M | — | |
PTGX | Ali Asif | — | Sep 11, 2024 | Proposed Sale | $44.49 | 14,203 | $631.9K | — |